breakpoint: cabozantinib after first-line ici in rcc
Published 3 years ago • 251 plays • Length 2:28Download video MP4
Download video MP3
Similar videos
-
2:43
cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in advanced rcc
-
4:12
cabosun trial of cabozantinib - could it change how we treat frontline rcc?
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
2:28
the role of cabozantinib in renal cell carcinoma
-
0:50
cassiope: cabozantinib in the real-word for rcc
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma
-
1:52
efficacy of targeted therapies after pd-1/pd-l1 blockade in metastatic renal cell carcinoma
-
2:14
managing renal cell carcinoma after progressing on checkpoint inhibitors
-
0:54
phase ib/ii trial of 177lu-girentuximab with cabozantinib and nivolumab in clear cell rcc
-
1:26
neoadjuvant cabozantinib in patients with locally advanced non-metastatic ccrcc
-
2:40
updates on the cabopre phase ii trial in patients with metastatic renal cell carcinoma
-
1:36
cabozantinib in patients with hcc refractory to checkpoint inhibitors
-
2:02
how cabozantinib is being used in practice for patients with rcc
-
1:46
cab atezo: a new treatment for naïve advanced ccrcc
-
1:43
rcc data at esmo 2020
-
1:25
managing side effects of cabozantinib treatment for metastatic renal cell carcinoma
-
2:58
phase ii trial of cabozantinib for patients with hcc previously treated with io
-
10:25
for hcps: learn about the cabometyx® (cabozantinib) mechanism of action